Assessing Variable Levels of Delegated Control – A Novel Measure of Trust

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial - The Lancet Haematology

Cancer in sub-Saharan Africa: a Lancet Oncology Commission - The Lancet Oncology

Deference (administrative state) - Ballotpedia

Vol 11, No suppl_1 Circulation: Cardiovascular Quality and Outcomes

The territorial impact of COVID-19: Managing the crisis across levels of government

The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza - National Academy of Medicine

CISSP Domain 3: Security Architecture Guide - DestCert

Labor and Labor Complications: A Nurse's Comprehensive Guide

Book Summary: Management 3.0. Management 3.0, by Trev de Vroome

Rise of the machines: Delegating decisions to autonomous AI - ScienceDirect

PDF) Assessing Variable Levels of Delegated Control – A Novel Measure of Trust